TickerFacts.

BIOCRYST PHARMACEUTICALS INC (BCRX) — Capital Expenditures

Annual figures by period end, from SEC filings.

2009-12-31: $604.0K2010-12-31: $325.0K2011-12-31: $55.0K2012-12-31: $113.0K2013-12-31: $30.0K2014-12-31: $106.0K2015-12-31: $5.12M2016-12-31: $5.28M2017-12-31: $328.0K2018-12-31: $366.0K2019-12-31: $343.0K2020-12-31: $514.0K2021-12-31: $2.38M2022-12-31: $1.35M2023-12-31: $2.17M2024-12-31: $1.12M2025-12-31: $2.47M$2.47M
2009-12-31Capital Expenditures (USD)2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$2.47M+119.6%2026-02-26From 2025-01-01
2024-12-31$1.12M-48.2%2026-02-26From 2024-01-01
2023-12-31$2.17M+60.5%2026-02-26From 2023-01-01
2022-12-31$1.35M-43.4%2025-02-25From 2022-01-01
2021-12-31$2.38M+364.0%2024-02-27From 2021-01-01
2020-12-31$514.0K+49.9%2023-02-27From 2020-01-01
2019-12-31$343.0K-6.3%2022-02-28From 2019-01-01
2018-12-31$366.0K+11.6%2021-03-01From 2018-01-01
2017-12-31$328.0K-93.8%2019-03-14From 2017-01-01
2016-12-31$5.28M+3.0%2019-03-14From 2016-01-01
2015-12-31$5.12M+4732.1%2018-03-12From 2015-01-01
2014-12-31$106.0K+253.3%2017-02-27From 2014-01-01
2013-12-31$30.0K-73.5%2016-02-26From 2013-01-01
2012-12-31$113.0K+105.5%2015-03-02From 2012-01-01
2011-12-31$55.0K-83.1%2014-03-10From 2011-01-01
2010-12-31$325.0K-46.2%2013-03-11From 2010-01-01
2009-12-31$604.0K—2012-03-06From 2009-01-01